期刊文献+

TNF-α诱导的胰岛素抵抗小鼠胰岛素敏感性及糖脂代谢的变化 被引量:3

The changes of insulin sensitivity and glucose-lipid metabolism in mice with TNF-α induced insulin resistance
下载PDF
导出
摘要 目的探讨TNF-α诱导的胰岛素抵抗(IR)小鼠胰岛素敏感性及糖脂代谢的变化。方法23只健康雄性C57BL/6J小鼠随机分为4组:高剂量(H)组、中剂量(M)组、低剂量(L)组分别给予腹腔注射6、3、1μg·kg-1.d-1的TNF-α,正常对照(NC)组注射等体积的生理盐水,共7天。采用静脉葡萄糖耐量试验(IVGTT)和3-[3H]葡萄糖为示踪剂的扩展胰岛素钳夹技术,评价小鼠胰岛素敏感性和糖脂代谢的变化。结果TNF-α处理后,小鼠FBG、血浆胰岛素(Ins)和FFA水平均增高,且H组明显高于NC、M和L组。IVGTT结果显示H组糖耐量减低,Ins释放水平明显高于其他组。在胰岛素钳夹术中,H组基础葡萄糖清除率(GDR)和肝糖输出率(HGP)明显高于NC组(P<0.01)。在钳夹稳态时,H组血浆Ins水平明显高于NC组(P<0.01),Ins对FFA的抑制作用较NC组明显降低(P<0.01),H组葡萄糖输注率(GIR)明显低于NC组(P<0.01);钳夹稳态时小鼠GDR明显增加,但H组GDR的增加仍明显低于NC组(P<0.01);钳夹结束时,NC组HGP被完全抑制,而H组仅被抑制59%。结论高剂量TNF-α(6μg·kg-1.d-1)处理可导致小鼠糖脂代谢紊乱以及肝和外周组织的IR。 Objective To investigate the effects of tumor necrosis factor-alpha (TNF-α) on insulin sensitivity and glucose-lipid metabolism in TNF-α-indueed IR mice. Methods Male C57BL/6J mice were given an intraperitoneal injection of TNF-α (H group, 6μg/kg; M group, 3μg/kg; L group, 1μg/kg;twice daily) and saline (NC group) for 7 days. The plasma glucose and insulin were assayed during intravenous glucose tolerance test (IVGTT) and hyperinsulinemic-euglycemic clamp combined with 3-[^3H] glucose as a tracer was carried out. Results After TNF-a treatment, fasting blood glucose (FBG), plasma insulin and free fatty acids (FFA) were significantly elevated in H group compared with NC, L and M groups (P〈0. 01 and P〈0. 05, respectively). There was a lower glucose tolerance in H group versus other three groups during IVGTT. The insulin release by glucose stimulation was higher in H group versus NC and L groups (P〈0. 01 and P〈0. 05). Basal glucose disappearance rate (GDR) and hepatic glucose production (HGP) were significantly increased in H group compared with NC group (P〈0.01). During the steady-state of clamp, plasma insulin levels were significantly increased in H group versus NC group (341.7±17. 7 vs 84. 7±5.5mU/L,P〈0.01). The suppressive effect of insulin on FFA was significantly blunted in H group compared with NC group (0.82±0.03 vs 0.43±0.07mmol/L,P〈0. 01). Steady-state glucose infusion rate (GIR) was significantly decreased in H group compared with NC group (39.1±2.3 vs 54.2±2. 2 mg·kg-1 ·min^-1 ,P〈0.01). Although GDR was increased in both group, but it was still lower in H group than in control group(47.9±0. 8 vs 53. 9±2. 0 mg. kg^-1. min^-1 ,P〈0. 01). As compared with baseline, HGP in the controls was almost completely suppressed during steady state of clamp, but in H group suppressed by approximately 41 %. Conclusions High-dose TNF-α treatment induces the abnormality of glucose-lipid metabolism and the insulin resistance of hepatic and peripheral tissue in mice.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2008年第12期711-714,共4页 Chinese Journal of Diabetes
基金 重庆市教委科研基金资助项目(编号:JK050304) 国家自然科学基金资助项目(编号:30270631,30370671) 美国NIH基金资助项目(编号:R01HL073267,DK066003)
关键词 肿瘤坏死因子 胰岛素抵抗 糖脂代谢 胰岛素钳夹 Tumor necrosis factor Insulin resistance Glucose-lipid metabolism Insulin clamp
  • 相关文献

参考文献9

  • 1Uysal KT, Wiesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature, 1997, 389: 610-614.
  • 2Zhang HH, Halbleib M, Ahmad F, et al. Tumor necrosis faetoralpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes, 2002, 51: 2929-2935.
  • 3Maria B, Malin F, Erik R, et al. The R6/2 transgenie mouse model of Huntington's disease develops diabetes due to deficient b-cell mass and exocytosis. Hum tool gene, 2005, 14: 565-574.
  • 4Kim HJ, Higashimori T, Park SY,et al. Differential effects of inter leukin-6 and -10 on skeletal muscle and liver insulin action in vlvo. Di abetes, 2004, 53: 1060-1067.
  • 5Goudriaan JR, Dahlmans VEH, Teusink B, et al. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res, 2003, 44: 2270-2277.
  • 6Defronzo RA, Gunnarsson R, Bfoknaan O, et al. Effects of insulin on peripheral and splanehnie glucose metabolism in noninsulin-dependent (type Ⅱ) diabetes mellitus. J Clin Invest, 1985, 76: 149-155.
  • 7Ohmura E, Hosaka D, Yazawa M, et al. Association of free fatty acids (FFA) and tumor necrosis factor-alpha (TNF-alpha) and insulin-resistant metabolic disorder. Horm Metabol Res, 2007, 39: 212-217.
  • 8Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistanee. Science, 1993, 259: 87-91.
  • 9Qin B, Qiu W, Avramoglu RK, et al. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolopoprotein B48-containing lipoproteins. Diabetes, 2007, 56: 450-461.

同被引文献33

  • 1杨媚,杨刚毅,李伶,李清明,阮华玲,阳皓,李钶,孙勤,唐毅,Gunther Boden.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. 被引量:76
  • 2Trujillo ME, Scherer PE. Adipose tissue-derived factors:impact on health and disease[J]. Endocr Rev,2006 ;27 (7) :762-78.
  • 3Sun Q, Li R, Yang M, et al. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats[J].Ann Med, 2009 ;41 (4) :311-20.
  • 4Phillips JW, Barringhaus KG, Sanders JM, et al. Rosiglitazone reduces the accelerated ,neointima formation after arterial injury in a mouse injury model of type 2 diabetes[J]. Circulation ,2003 ; 108 ( 16 ) : 1994-9.
  • 5Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin : a protein secreted by visceral fat that mimics the effects of insulin[J]. Science, 2005;307 (5708) :426-30.
  • 6Ingelsson E, Larson MG, Fox CS, et al. Clinical correlates of circulating visfatin levels in a community-based sample[J].Diabetes Care, 2007;30 (5) :1278-80.
  • 7Yamawaki H, Hara N, Okada M, et al. Visfatin causes endothelium-dependent relaxation in isolated blood vessels [J]. Biochem Biophys Res Commun ,2009 ;383 (4) :503-8.
  • 8Combs TP, Berg AH, Obici S,et al. Endogenous glucose production is in- hibited by the adipose-derived protein Acrp30 [J].J Clin Invest,2001 ; 108(12) :1875-81.
  • 9Yamauchi T, Kamon J, Waki H,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity[ J]. Nat Med,2001 ;7(8) :941-6.
  • 10Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Research and Clinical Practice,2010,87:4-14.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部